Citation sources

Updated weekly. Details via Crossref

Crossref	Scopus	Google Scholar
7	8	Search

2024	CD133 expression is associated with less DNA repair, better response to chemotherapy and survival in ER-positive/HER2-negative breast cancer Breast Cancer Research and Treatment Takumi Sato, Masanori Oshi, Jing Li Huang, Kohei Chida, Arya Mariam Roy, Itaru Endo, Kazuaki Takabe
2021	Alteration in stemness causes exclusivity between Epstein–Barr virus-positivity and microsatellite instability status in gastric cancer Gastric Cancer Younghoon Kim, Yun-Joo Shin, Xianyu Wen, Nam-Yun Cho, Meihui Li, Yun-Jee Kim, Sang Hyun Song, Gyeong Hoon Kang
2021	The shifting paradigm of colorectal cancer treatment: a look into emerging cancer stem cell-directed therapeutics to lead the charge toward complete remission Expert Opinion on Biological Therapy Jessica Kopenhaver, Madison Crutcher, Scott A. Waldman, Adam E. Snook
2020	ARE STEM CELL MARKER EXPRESSION AND CD133 ANALYSIS RELEVANT TO DIFFERENTIATE COLORECTAL CANCER? ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) Leticia Elizabeth Augustin CZECZKO, Carmen Australia Paredes Marcondes RIBAS, Nicolau Gregori CZECZKO, Thelma Larocca SKARE, Camila Kienen YAMAKAWA, Guilherme GIONEDIS, Cecilia VASCONCELOS, Fabiola Pabst BREMER, Diogo Francesco CASTOLDI, Martin GASSER, Ana Maria WAAGA-GASSER
2020	DNA damage response and resistance of cancer stem cells Cancer Letters Etna Abad, Dmitry Graifer, Alex Lyakhovich
2019	Expression of CD133 is associated with poor prognosis in stage II colorectal carcinoma Medicine Youn Young Park, Chang Hyeok An, Seong Taek Oh, Eun Deock Chang, Jaeim Lee
	Additional cited-by details will be shown when available from Crossref